YFL031C-A Antibody

What is YFL031C-A and why is it studied in yeast research?

YFL031C-A is a protein encoded in the Saccharomyces cerevisiae genome (Baker's yeast strain ATCC 204508/S288c). Studying this protein through antibody-based detection methods is valuable for understanding fundamental cellular processes in yeast, which often serve as model systems for eukaryotic cell biology. The protein is typically investigated using specific antibodies like CSB-PA823495XA01SVG that recognize the target with high specificity . The antibody enables researchers to track protein expression, localization, and interactions, providing insights into yeast cellular functions that may have relevance to conserved pathways in higher eukaryotes.

What applications is the YFL031C-A antibody validated for?

The YFL031C-A antibody (CSB-PA823495XA01SVG) has been validated for enzyme-linked immunosorbent assay (ELISA) and Western blotting (WB) applications to ensure specific identification of the antigen . These techniques allow researchers to detect and quantify the presence of YFL031C-A protein in various experimental contexts. While the antibody is primarily validated for these two applications, researchers should perform their own validation if using it for other techniques such as immunoprecipitation, immunohistochemistry, or flow cytometry, as cross-application validation is essential for reliable results.

How should YFL031C-A antibody be stored to maintain its activity?

Upon receipt, the YFL031C-A antibody should be stored at -20°C or -80°C to maintain its stability and activity . Repeated freeze-thaw cycles should be avoided as they can lead to antibody degradation and reduced performance. The antibody is provided in a storage buffer containing 0.03% Proclin 300 as a preservative and 50% Glycerol, 0.01M PBS, pH 7.4 as constituents . For short-term use, aliquots can be kept at 4°C, but long-term storage requires freezing. Proper storage ensures the maintenance of antibody binding capacity and specificity across experiments.

What is the species reactivity profile of YFL031C-A antibody?

The YFL031C-A antibody has been specifically tested and validated for reactivity with Saccharomyces cerevisiae (strain ATCC 204508/S288c), commonly known as Baker's yeast . This narrow reactivity profile makes it particularly valuable for yeast-specific research but limits its application in cross-species studies. Researchers should note that cross-reactivity with other yeast species or strains has not been extensively characterized, and additional validation would be necessary for applications involving different organisms.

How does polyclonal YFL031C-A antibody specificity compare to monoclonal alternatives in complex yeast proteome analyses?

The specificity profile of polyclonal antibodies is inherently more complex than monoclonal alternatives, with potential recognition of similar epitopes on related proteins. Recent advances in antibody engineering, as described in the literature, have demonstrated that computational modeling can help predict and design antibody specificity profiles . For yeast proteome analyses, researchers should consider:

• Validation through knockout/deletion strains lacking YFL031C-A

• Pre-absorption with recombinant YFL031C-A protein to confirm specificity

• Comparative analysis using alternative detection methods

When extremely high specificity is required, computational approaches that disentangle different binding modes could be applied, similar to those described for therapeutic antibody development .

What methodological approaches can improve YFL031C-A antibody specificity in multi-protein complex studies?

When studying YFL031C-A in the context of multi-protein complexes, researchers can employ several methodological approaches to enhance antibody specificity:

• Sequential immunoprecipitation: Performing sequential pulls with different antibodies targeting distinct complex components can reduce nonspecific binding.

• Crosslinking optimization: Experimenting with various crosslinking agents and conditions to preserve protein-protein interactions while minimizing background.

• Specificity blockade: Similar to approaches described for other antibodies, pre-incubation with non-specific IgG of the same isotype can potentially reduce nonspecific binding, although this may not always improve tumor-specific uptake as demonstrated in some studies .

• Detergent screening: Systematic testing of different detergent types and concentrations can help preserve specific interactions while disrupting nonspecific binding.

• Mass spectrometry validation: Confirming the identity of immunoprecipitated proteins through mass spectrometry to distinguish between specific and nonspecific interactions.

These approaches should be empirically tested and optimized for each specific experimental context to determine the most effective strategy for YFL031C-A detection in complex systems.

What are the optimal conditions for Western blot detection of YFL031C-A protein?

For optimal Western blot detection of YFL031C-A protein using the validated antibody, researchers should consider the following protocol parameters:

This protocol should be optimized for specific experimental conditions, particularly with respect to antibody dilution and incubation parameters. Validation using appropriate positive and negative controls is essential for confirming specificity .

How can researchers optimize immunoprecipitation protocols using YFL031C-A antibody?

While the YFL031C-A antibody is not specifically validated for immunoprecipitation, researchers interested in adapting it for this application should consider the following optimization steps:

• Antibody coupling: Covalently couple the antibody to protein A/G beads or magnetic beads to prevent antibody leaching during elution.

• Lysis buffer optimization: Test different lysis buffers varying in salt concentration (100-500 mM), detergent type (Triton X-100, NP-40, CHAPS) and concentration (0.1-1%), and pH (6.8-8.0) to identify conditions that preserve protein interactions while minimizing background.

• Cross-linking consideration: For transient or weak interactions, consider reversible cross-linking approaches using DSP (dithiobis[succinimidyl propionate]) or formaldehyde.

• Pre-clearing strategy: Implement sample pre-clearing with protein A/G beads alone to reduce nonspecific binding.

• Control selections: Include isotype-matched control antibodies and, if possible, immunoprecipitation from yeast strains lacking YFL031C-A.

A systematic approach to optimization, testing multiple conditions in parallel, will help establish a reliable protocol for YFL031C-A immunoprecipitation studies.

What considerations should guide experimental design when using YFL031C-A antibody for co-localization studies?

For co-localization studies involving YFL031C-A detection in yeast cells, researchers should address several key experimental design considerations:

• Fixation method selection: Different fixation methods (paraformaldehyde, methanol, or combinations) can differentially affect epitope accessibility and cellular structure preservation. Testing multiple fixation protocols is recommended.

• Permeabilization optimization: The yeast cell wall presents unique challenges for antibody penetration. Enzymatic digestion (zymolyase, lyticase) followed by detergent permeabilization should be systematically optimized.

• Blocking strategy: Extended blocking (2+ hours) with higher concentrations of blocking agents may be necessary to reduce background in yeast cells.

• Antibody validation controls: Include appropriate controls such as:

  • Secondary antibody-only controls

  • Non-expressing yeast strains

  • Peptide competition assays to confirm specificity

• Confocal parameters: Optimize image acquisition settings including:

  • Z-stack interval spacing (0.2-0.5 μm recommended)

  • Pinhole settings (1 Airy unit as starting point)

  • Sequential scanning to prevent channel bleed-through

These considerations should guide the development of robust co-localization protocols that minimize artifacts and maximize detection specificity.

How should researchers approach contradictory results when using YFL031C-A antibody across different detection methods?

When encountering contradictory results between different detection methods using the YFL031C-A antibody, researchers should implement a systematic troubleshooting approach:

• Evaluate epitope accessibility: Different detection methods expose different epitopes. Since the YFL031C-A antibody is polyclonal, certain epitopes may be accessible in some methods but masked in others due to protein folding, fixation effects, or interaction partners.

• Consider post-translational modifications: The antibody was raised against recombinant protein , which may lack post-translational modifications present in native yeast cells. Modifications could affect antibody recognition in application-specific ways.

• Implement validation hierarchy: Establish a hierarchy of validation methods, with orthogonal techniques (e.g., mass spectrometry, genetic tagging) serving as arbiters for contradictory immunodetection results.

• Analyze subcellular fractionation effects: Differences in results between whole-cell lysates and subcellular fractions may indicate compartment-specific interactions or modifications affecting antibody recognition.

• Evaluate method-specific interference: Components specific to certain methods (e.g., detergents in Western blotting, fixatives in immunofluorescence) may differentially impact antibody performance.

Systematic documentation of all experimental variables across contradictory experiments is essential for identifying the source of discrepancies.

What statistical approaches are most appropriate for quantifying YFL031C-A expression in heterogeneous yeast populations?

When analyzing heterogeneous yeast populations for YFL031C-A expression, several statistical approaches should be considered:

• Population distribution analysis: Rather than simple means, analyze full distribution patterns using:

  • Kernel density estimation to visualize population heterogeneity

  • Mixture modeling to identify subpopulations

  • Coefficient of variation as a metric for population heterogeneity

• Single-cell correlation analysis: For co-expression studies, implement:

  • Spearman's rank correlation for non-parametric assessment

  • Information theory metrics (mutual information) for capturing non-linear relationships

  • Spatial correlation statistics for localization studies

• Temporal dynamics quantification: For time-course experiments:

  • Time-series clustering to identify expression pattern groups

  • Dynamic time warping to align expression profiles with different kinetics

  • Fourier transform analysis for periodic expression patterns

• Sample size determination: Power analysis should be performed with consideration for:

  • Expected effect size based on preliminary data

  • Population heterogeneity estimates

  • Multiple testing correction requirements

These approaches help ensure robust quantification while accounting for the inherent heterogeneity in yeast populations, particularly in studies of protein expression that may vary with cell cycle stage or environmental conditions.

How can researchers distinguish between specific and non-specific binding when using YFL031C-A antibody in complex experimental systems?

Distinguishing specific from non-specific binding is critical when using antibodies like YFL031C-A in complex systems. Researchers should employ a multi-faceted approach:

• Competitive binding assays: Pre-incubate the antibody with purified recombinant YFL031C-A protein before application to samples. Specific signals should be reduced or eliminated in a concentration-dependent manner.

• Genetic validation: Utilize YFL031C-A deletion strains as negative controls. Any signal detected in these samples indicates non-specific binding.

• Isotype control experiments: Compare binding patterns with isotype-matched non-specific IgG to identify background binding patterns .

• Dilution series analysis: Specific binding typically shows a dose-dependent relationship with antibody concentration, while non-specific binding may show different patterns.

• Cross-validation with orthogonal detection methods: Confirm findings using alternative detection approaches such as:

  • Mass spectrometry identification of bound proteins

  • GFP-tagged YFL031C-A expression

  • RNA expression correlation analysis

The combination of these approaches provides stronger evidence for binding specificity than any single method alone.

How can computational modeling improve YFL031C-A antibody specificity for challenging applications?

Recent advances in computational modeling offer promising approaches for improving antibody specificity, which could be applied to challenging applications involving YFL031C-A antibody:

• Epitope mapping and engineering: Computational prediction of YFL031C-A epitopes can guide the development of more specific antibodies or the refinement of existing ones. This approach involves:

  • In silico analysis of protein structure to identify surface-exposed regions

  • Prediction of epitope-paratope interactions through molecular dynamics simulations

  • Design of alternative binding sites for enhanced specificity

• Machine learning for cross-reactivity prediction: As described in recent literature, machine learning approaches can identify potential cross-reactive targets by analyzing structural and sequence similarities between the intended target and other proteins in the proteome .

• Biophysics-informed models: These models, which incorporate thermodynamic principles of protein-protein interactions, can distinguish between different binding modes and predict specificity profiles . For YFL031C-A antibody, such models could:

  • Identify potential off-target binding sites

  • Guide antibody engineering to enhance specificity

  • Predict performance in different experimental conditions

• Integration with high-throughput selection data: Combining computational models with data from phage display experiments can yield insights into antibody binding characteristics that inform experimental design and interpretation .

These computational approaches represent an emerging frontier in antibody research that could significantly enhance the specificity and utility of antibodies like YFL031C-A for challenging applications in complex biological systems.

What are the methodological considerations when adapting YFL031C-A antibody for super-resolution microscopy?

Adapting the YFL031C-A antibody for super-resolution microscopy techniques requires careful methodological considerations:

• Labeling strategy optimization:

  • Direct labeling with smaller fluorophores (Alexa Fluor dyes) typically yields better resolution than secondary antibody approaches

  • Consider using Fab fragments rather than whole IgG to reduce the displacement between epitope and fluorophore

  • Test different fluorophore-to-antibody ratios to balance signal strength and potential fluorophore self-quenching

• Sample preparation refinement:

  • Optimize fixation protocols to preserve ultrastructure while maintaining epitope accessibility

  • For yeast cells, enzymatic cell wall digestion parameters are critical and should be systematically tested

  • Consider expansion microscopy protocols to physically separate epitopes in densely packed structures

• Imaging parameter considerations:

  • Determine optimal photoswitching buffer compositions for techniques like STORM/PALM

  • For STED microscopy, test different depletion laser powers to balance resolution and photobleaching

  • Implement drift correction strategies using fiducial markers

• Validation approaches:

  • Compare localization patterns with orthogonal super-resolution techniques

  • Correlate with electron microscopy for structural validation

  • Use nearest neighbor distance analysis to assess specific versus random distributions

These methodological refinements are essential for successful adaptation of YFL031C-A antibody to super-resolution microscopy applications, particularly given the challenges posed by the yeast cell architecture.

What are the most common technical challenges when using YFL031C-A antibody and how can they be addressed?

Researchers working with YFL031C-A antibody may encounter several technical challenges. Here are the most common issues and recommended solutions:

For each challenge, systematic optimization starting from established protocols and proceeding with controlled parameter adjustments will help identify optimal conditions for specific experimental contexts.

How should researchers approach epitope mapping for YFL031C-A to enhance experimental design?

Epitope mapping provides valuable information for optimizing experimental design with the YFL031C-A antibody. Researchers should consider the following approach:

• In silico prediction: Begin with computational prediction of likely epitopes based on:

  • Hydrophilicity profiles

  • Surface accessibility calculations

  • Secondary structure predictions

  • Conservation analysis across related yeast species

• Peptide array analysis: Generate overlapping peptide arrays covering the YFL031C-A sequence to identify binding regions empirically:

  • 15-20 amino acid peptides with 5-10 amino acid overlaps

  • Include both linear and, if possible, conformational epitope mimics

  • Quantify binding affinity for each peptide region

• Mutagenesis validation: For critical applications, confirm key epitopes through:

  • Alanine scanning mutagenesis of predicted epitope residues

  • Expression of truncated protein variants lacking specific regions

  • Competition assays with mutant proteins

• Application-specific epitope accessibility assessment: Determine how experimental conditions affect epitope accessibility:

  • Test different fixation methods for microscopy applications

  • Evaluate denaturing versus native conditions for biochemical assays

  • Assess epitope masking by known interaction partners

This methodical approach to epitope mapping will inform experimental design decisions, troubleshooting strategies, and interpretation of results across different applications of the YFL031C-A antibody.

What emerging technologies might enhance YFL031C-A detection and analysis in future research?

Several emerging technologies hold promise for enhancing YFL031C-A detection and analysis in future research:

• Proximity labeling techniques: Methods like BioID, APEX, or TurboID could be combined with YFL031C-A antibody validation to map protein interaction networks with temporal and spatial resolution in living yeast cells.

• Single-molecule tracking: Adaptation of the antibody for single-particle tracking through quantum dot conjugation or development of nanobody alternatives could reveal dynamic behaviors of YFL031C-A in living cells.

• Intracellular antibody expression (intrabodies): Development of intrabodies derived from the YFL031C-A antibody sequence could enable live-cell tracking of the native protein without fixation artifacts.

• Integrative multi-omics approaches: Combining antibody-based detection with transcriptomics, proteomics, and metabolomics data could provide comprehensive understanding of YFL031C-A function in various cellular contexts.

• AI-enhanced image analysis: Deep learning approaches for image segmentation and feature extraction could improve quantitative analysis of YFL031C-A localization patterns across heterogeneous cell populations.

• Biophysically-informed antibody engineering: As demonstrated in recent literature, incorporating biophysical constraints into models can enable the design of antibodies with enhanced specificity profiles, potentially leading to next-generation YFL031C-A detection reagents .

These emerging technologies represent promising directions for expanding the utility and applications of YFL031C-A antibody in future research endeavors.

How can researchers contribute to improving YFL031C-A antibody resources for the scientific community?

Researchers can make valuable contributions to improving YFL031C-A antibody resources through several collaborative approaches:

• Validation data sharing: Systematically document and share antibody validation data across different applications, cell types, and experimental conditions in public repositories or supplementary materials.

• Protocol optimization repositories: Contribute optimized protocols for challenging applications to resources like protocols.io, including detailed troubleshooting notes and parameter optimization data.

• Reference standard development: Establish community reference standards for YFL031C-A detection, including positive and negative control samples that can be distributed to ensure cross-laboratory consistency.

• Application expansion: Systematically test and validate the antibody for applications beyond the manufacturer-validated ELISA and Western blot methods .

• Reagent generation and sharing: Develop and share additional tools that complement antibody-based detection, such as:

  • Expression constructs for tagged YFL031C-A

  • Yeast strains with modified YFL031C-A expression

  • Alternative detection reagents (aptamers, nanobodies)

• Computational resource development: Contribute to or develop computational tools for predicting antibody specificity, optimizing experimental design, or analyzing complex data from YFL031C-A studies .